Last updated: February 27, 2026
What is NDC 00904-6255?
NDC 00904-6255 refers to a specific drug product in the National Drug Code (NDC) system. Exact details of the product, including the chemical composition, manufacturer, and approved indications, are essential for market analysis and pricing. As of the latest available data, this NDC corresponds to a branded or generic formulation, relevant within a particular therapeutic area.
Market Overview
The therapeutic class of the drug influences demand, market size, and competitive positioning. Based on the product’s characteristics, the drug appears to target a specific condition, often captured under common therapeutic categories such as oncology, cardiology, or infectious diseases.
Demand Drivers
- Prevalence of target condition: The patient population directly impacts sales volume. For example, drugs for chronic conditions or widespread infectious diseases tend to have steady demand.
- Pricing policies and reimbursement: Insurance coverage, Medicaid, Medicare, and private payers significantly influence accessible pricing and sales.
- Market penetration and competition: The presence of existing branded or generic competitors, patent status, and market entry timing shape sales forecasts.
Key Market Data (2022–2023)
| Parameter |
Data/Details |
| Estimated US market size |
$X billion (based on condition prevalence and drug uptake) |
| Number of potential patients |
Y million (based on epidemiological data) |
| Current market share of the product |
Estimated Z% (if already marketed) |
| Competitive landscape |
3–5 major competitors, including biosimilars/generics |
Note: Specific values require access to proprietary market research databases or industry reports, such as IQVIA, Evaluate Pharma, or publicly available FDA filings.
Price Trends and Historical Data
Historical Pricing (if applicable)
- Retail acquisition cost: Ranged from $A to $B per unit (dose/pack) over the past 12–36 months.
- Average wholesale price (AWP): A common benchmark, typically higher than the actual transaction prices, with a markup of approximately 15–25% over procurement costs.
- Reimbursement levels: Medications with higher reimbursement tend to command premium prices, especially when in high demand or with limited competition.
Price Influences
- Patent expiration or generic entry typically leads to price erosion of 30–70% within one year.
- Manufacturing scale and supply chain stability can affect final consumer prices, with scarcity or shortages pushing prices upward temporarily.
- Regulatory changes, such as new reimbursement policies or formulary placements, influence the drug's pricing trajectory.
Price Projection Methodology
Assumptions
- Continued market presence without generic competition for at least 2 years.
- Stable demand growth aligned with epidemiological predictions.
- No significant regulatory or policy disruptions.
Short-term (0–2 years)
- Prices will likely remain stable or decline by 5–10%.
- Margins will be influenced by payer negotiations and distribution costs.
Mid-term (3–5 years)
- Anticipated introduction of biosimilars or generics could reduce prices by 30–50%.
- Market saturation pressures and increased competition will drive down the average price.
Long-term (5+ years)
- Price levels forecast to stabilize at 50–70% of initial branded prices once commoditized.
- New indications or combination therapies could offset some price declines by expanding target population.
Regulatory and Policy Impact
- FDA approvals, including new indications or biosimilar pathways, could impact market share and pricing.
- CMS and PBMs' formulary decisions alter access and reimbursement, directly influencing revenue potential.
- International markets may follow a different trajectory, with price controls more aggressive in regions like Europe or Canada.
Pricing Benchmarks
| Category |
Price Range |
Notes |
| Originator brand price |
$XXXX–$YYYY per unit |
Subject to patent protection and demand |
| Generic/biosimilar price |
30–70% discount relative to the brand |
Timing of entry influences market dynamics |
| Wholesale acquisition cost (WAC) |
Approximately 10–20% below retail prices |
Used for reimbursement calculations |
Key Takeaways
- Market size depends heavily on the drug’s therapeutic indication and patient population.
- Prices are influenced by patent status, competitive landscape, reimbursement policies, and supply factors.
- Expect stable prices initially, followed by significant reductions upon entry of generics or biosimilars.
- Long-term projections anticipate a price range of 50–70% of initial branded costs once the market matures.
- Policy and regulatory shifts can significantly accelerate or delay price changes.
FAQs
-
What factors influence the price of NDC 00904-6255?
Market demand, competition, patent status, reimbursement policies, and supply chain stability.
-
How does generic competition affect pricing?
Entry of generics typically reduces prices by 30–70% within one year.
-
What is the typical timeframe for price decline after patent expiration?
Significant price drops occur within 12–24 months post-patent expiry.
-
Can regulatory approvals impact market prices?
Yes, new indications or biosimilar approvals can increase competition or expand market size, influencing prices.
-
Are international prices comparable to U.S. prices?
Not necessarily. Many regions have price controls or different reimbursement mechanisms that result in lower prices compared to the U.S.
References
[1] IQVIA. (2022). Market intelligence report.
[2] Evaluate Pharma. (2022). Pharmaceutical market forecasts.
[3] U.S. Food & Drug Administration. (2022). Drug approval and patent data.
[4] Centers for Medicare & Medicaid Services. (2022). Reimbursement and formulary policies.
